Eszopiclone Treatment & Cortisol Responsivity

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

August 31, 2009

Conditions
Insomnia
Interventions
DRUG

eszopiclone

6 weeks standard oral therapy

Trial Locations (1)

02906

Butler Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Butler Hospital

OTHER